4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-080133
Chief Scientific Officer sold 43,700 shares at $20.09 ($877,933)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reich Kristian Chief Scientific Officer | 2026-07-20 | Sale 10b5-1 | −43,700 | $20.09 | $877,933 | 2,764,746 | I |
| Open-market sales · 43,700 sh · avg $20.09 · $877,933 | |||||||
Loading xslF345X06/ownership.xml…